Interstate Blood Bank

What Interstate Blood Bank does

Interstate Blood Bank, Inc. (IBBI) is a US-based whole blood collection and supply company headquartered in Memphis, Tennessee, founded in 1949 and operating as a wholly-owned subsidiary of Grifols, S.A. since the 2019 acquisition. The company operates a multi-state network of physical blood donor centers where individual donors aged 18–70 and weighing at least 110 pounds donate whole blood in approximately 30-minute sessions, with donors compensated for their time and limited to one donation per 8-week period. Walk-in donation is supported at all sites, and a ZIP-code-based locator drives discovery across the network.

IBBI's core technology stack is conventional: physical donor centers, on-site pre-donation screening using routine medical-history questionnaires, and centralized state-of-the-art testing facilities in Memphis, TN where laboratory technicians conduct extensive infectious-disease screening on every donation collected. The Memphis facility performs over 2 million tests annually, screening each unit for Hepatitis B, Hepatitis C, HIV, and Syphilis. There is no disclosed AI/ML, app, API, or third-party platform integration in the data; distribution of collected product is conducted off-platform through B2B channels.

The revenue model is a transaction-fee whole blood collection and distribution business. IBBI earns by collecting whole blood from compensated donors, processing and testing it, and supplying screened product to therapeutic and diagnostic industry buyers who use it in the production of testing and diagnostic tools. Customer segmentation is horizontal across the therapeutic and diagnostic industries, with end-buyers being enterprise-scale manufacturers rather than individual consumers. Revenue mechanics are not publicly disclosed at the subsidiary level, and pricing for donor compensation is set per location and not listed publicly. The company is private, operates only in the United States, and is reported as actively operating within Grifols' broader plasma and blood products network.

Name

Interstate Blood Bank

Legal name

Interstate Blood Bank, Inc.

Website

https://interstatebloodbank.com

Company type

Private

Founded year

1949

Operating status

Operating

Headcount range

251–500 employees

Short description

Interstate Blood Bank, Inc. (IBBI) is a US-based subsidiary of Grifols, S.A. that operates a network of blood donor centers collecting whole blood from compensated individual donors, screens each donation for infectious diseases at its Memphis, TN testing facility, and supplies the tested product to therapeutic and diagnostic industry buyers.

Ownership category

akta.pro rank

Product category

Blood Banking Services

NAICS

Blood and Organ Banks (621991), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

akta.pro secondary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

Keywords

• Whole blood collection
• Blood donor services
• Blood component supply
• Donor screening testing
• Diagnostic industry supply

Headquarters

HQ city

Memphis

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D

Revenue model

1. Whole Blood Collection and Distribution: Collects human blood from donors through a network of blood donor centers. The blood is supplied to therapeutic and diagnostic industries for the production of testing and diagnostic tools that contribute to saving and improving lives. Grifols acquired IBBI in 2019.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Interstate Blood Bank, Inc. (IBBI) collects human whole blood from compensated donors through its network of U.S. donor centers, performs comprehensive pathogen screening at its Memphis, TN testing facility (over 2 million tests annually for Hepatitis B, Hepatitis C, HIV, and Syphilis), and supplies the resulting blood products to therapeutic and diagnostic industries for use in producing testing and diagnostic tools.

Product overview

Interstate Blood Bank, Inc. (IBBI) operates as a network of blood donor centers acquired by Grifols in 2019. The company provides whole blood donation services through its physical donor center locations and supports the therapeutic and diagnostic industries with collected blood products. The core offerings include: the Whole Blood Donation Service (where donors aged 18-70 can donate with compensation), the Blood Donor Center Network (with locations including a Miami facility at Midpoint), and Blood Testing Services (state-of-the-art Memphis, TN facilities performing over 2 million tests annually for Hepatitis B, Hepatitis C, HIV, and Syphilis). This is a single-service healthcare offering, not a platform architecture.

Differentiator

Problem solved

Functional benefit

Products and services

• Whole Blood Donation Service A blood donation service where healthy individuals aged 18-70 who weigh at least 110 lbs can donate whole blood at IBBI donor centers. The donation process takes approximately 30 minutes, donors are compensated for their time, and donors cannot donate more than once in any 8-week period. Collected donations are screened and supplied to therapeutic and diagnostic industries.
• Blood Donor Center Network A network of physical blood donor centers operated by IBBI across the United States where individual donors can donate whole blood. Locations are searchable by ZIP code on the company website, walk-ins are welcome, and centers include a new Miami facility at Midpoint shopping area.
• Blood Testing Services

Quantifiable outcome

• Over 2 million tests performed annually on collected donations

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Grifols, S.A.coreStrategic or Co-development Partner · 1 January 2019Grifols acquired Interstate Blood Bank, Inc. (IBBI) and its network of blood donor centers in 2019. As a subsidiary of Grifols, IBBI collects human blood to support the therapeutic and diagnostic industries in the production of testing and diagnostic tools. Grifols is a company since 1909 that develops, produces and markets innovative medicines, solutions and services in more than 110 countries.

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• American Red Cross Biomedical Services: Largest U.S. nonprofit blood collector supplying approximately 40% of the nation's blood supply. Comparable in operating blood donor centers and supplying blood products downstream, but relies on volunteer donors, giving it a structural cost advantage over compensated collectors like IBBI.
• BioLife Plasma Services: Subsidiary of Takeda that operates a large U.S. network of for-profit plasma donation centers, paying donors for their time. Closely comparable business model to IBBI's whole-blood donor center network with similar direct-to-donor GTM and compensated donor base.
• Octapharma Plasma: U.S. subsidiary of Octapharma AG operating a network of for-profit plasma donation centers paying donors per donation. Directly comparable donor-compensation business model and downstream supply into therapeutic and diagnostic product manufacturing.
• Vitalant: One of the largest nonprofit blood collection organizations in the U.S., operating donation centers that supply blood products to hospitals and industry. Comparable in core blood collection activity but differs in nonprofit/volunteer model vs IBBI's compensated donor approach.
• CSL Plasma: Subsidiary of CSL Limited operating one of the world's largest plasma collection networks with hundreds of U.S. donor centers. Directly comparable for-profit, compensated-donor collection model that supplies plasma for downstream fractionation into therapeutic and diagnostic products.

Broad incumbents

• Grifols, S.A. Public parent company of IBBI and one of the world's largest plasma-derived therapy companies. Directly comparable as it operates a global plasma collection network and fractionates plasma into therapeutic and diagnostic raw materials, encompassing the full value chain that IBBI feeds into.
• Kedrion Biopharma: Global plasma-derived therapy company that operates its own plasma collection network in the U.S. and internationally. Comparable as both a collector and a downstream fractionator, providing an integrated alternative to IBBI/Grifols' supply chain.
• Bio Products Laboratory (BPL): Plasma collector and fractionator with U.S. donation centers and global therapeutic product distribution. Comparable in operating compensated donor centers and supplying plasma-derived therapeutic and diagnostic materials.

Regional players

• New York Blood Center: Large nonprofit blood collector serving the greater New York region with collection, testing, and distribution operations. Comparable in core blood-bank activity and testing infrastructure but regional in geographic scope and nonprofit in structure.

Others

• Haemonetics Corporation: Medical device company providing blood and plasma collection technology, software, and disposables used by donor centers globally. Comparable as an adjacent ecosystem participant whose products enable the operation of blood collection networks like IBBI's.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/interstatebloodandplasma

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Interstate Blood Bank